These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16104078)

  • 41. Pioglitazone and bladder cancer.
    Hillaire-Buys D; Faillie JL; Montastruc JL
    Lancet; 2011 Oct; 378(9802):1543-4; author reply 1544-5. PubMed ID: 22035550
    [No Abstract]   [Full Text] [Related]  

  • 42. Pioglitazone and bladder cancer.
    Ryder RE
    Lancet; 2011 Oct; 378(9802):1544; author reply 1544-5. PubMed ID: 22035551
    [No Abstract]   [Full Text] [Related]  

  • 43. Acute coronary syndromes: Aleglitazar trial findings reported.
    Mearns BM
    Nat Rev Cardiol; 2014 Jun; 11(6):311. PubMed ID: 24736759
    [No Abstract]   [Full Text] [Related]  

  • 44. Thiazolidinediones for initial treatment of type 2 diabetes?
    Nathan DM
    N Engl J Med; 2006 Dec; 355(23):2477-80. PubMed ID: 17145743
    [No Abstract]   [Full Text] [Related]  

  • 45. The PROactive study: some answers, many questions.
    Yki-Järvinen H
    Lancet; 2005 Oct; 366(9493):1241-2. PubMed ID: 16214581
    [No Abstract]   [Full Text] [Related]  

  • 46. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.
    Charbonnel B
    Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387
    [No Abstract]   [Full Text] [Related]  

  • 47. Aleglitazar, a dual PPARα and PPARγ agonist for the potential oral treatment of type 2 diabetes mellitus.
    Lecka-Czernik B
    IDrugs; 2010 Nov; 13(11):793-801. PubMed ID: 21046527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of proliferative diabetic retinopathy with insulin use and microalbuminuria.
    Chu SH; Li AH
    Arch Ophthalmol; 2010 Jan; 128(1):146; author reply 146-7. PubMed ID: 20065240
    [No Abstract]   [Full Text] [Related]  

  • 49. Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.
    Misbin RI
    Diabetes Care; 2007 Dec; 30(12):3141-4. PubMed ID: 18042753
    [No Abstract]   [Full Text] [Related]  

  • 50. Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients.
    Tseng CH; Huang TS
    Diabetes Res Clin Pract; 2005 Nov; 70(2):193-4. PubMed ID: 16188579
    [No Abstract]   [Full Text] [Related]  

  • 51. [The benefit of pioglitazone in patients with diabetes mellitus type 2 and cardiovascular complications].
    Olsovský J
    Vnitr Lek; 2005 Dec; 51(12):1412. PubMed ID: 16430111
    [No Abstract]   [Full Text] [Related]  

  • 52. Which oral drug is right for your type 2 diabetes? New thinking on oral drug combinations that can provide better glycemic control.
    Health News; 2005 Feb; 11(2):10-1. PubMed ID: 15732153
    [No Abstract]   [Full Text] [Related]  

  • 53. [Is there a need of glitazones in the treatment of diabetes?].
    Halse J
    Tidsskr Nor Laegeforen; 2007 Aug; 127(16):2124; author reply 2124. PubMed ID: 17717584
    [No Abstract]   [Full Text] [Related]  

  • 54. Modelling lifetime metabolic progression and cost effectiveness of treatment strategies for type 2 diabetes.
    Palmer AJ; Currie CJ
    Pharmacoeconomics; 2006; 24(9):927-9; author reply 929-35. PubMed ID: 16942126
    [No Abstract]   [Full Text] [Related]  

  • 55. Diabetes drug safety update: Avandia and your heart.
    Johns Hopkins Med Lett Health After 50; 2010 Jun; 22(4):1-2, 7. PubMed ID: 20572316
    [No Abstract]   [Full Text] [Related]  

  • 56. Rosiglitazone.
    Simon D
    Prim Care Diabetes; 2009 May; 3(2):123-4. PubMed ID: 19482530
    [No Abstract]   [Full Text] [Related]  

  • 57. Diabetes drug is linked with bladder cancer risk.
    Voelker R
    JAMA; 2012 Jun; 307(24):2577. PubMed ID: 22735407
    [No Abstract]   [Full Text] [Related]  

  • 58. Triple oral therapy for type 2 diabetes.
    Bell DS
    Diabetes Res Clin Pract; 2007 Dec; 78(3):313-5. PubMed ID: 17320237
    [No Abstract]   [Full Text] [Related]  

  • 59. Hypoglycemic activity of a series of alpha-alkylthio and alpha-alkoxy carboxylic acids related to ciglitazone.
    Hulin B; Newton LS; Lewis DM; Genereux PE; Gibbs EM; Clark DA
    J Med Chem; 1996 Sep; 39(20):3897-907. PubMed ID: 8831756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
    Khanderia U; Pop-Busui R; Eagle KA
    Ann Pharmacother; 2008 Oct; 42(10):1466-74. PubMed ID: 18698014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.